Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haddad

Showing results (681-690 of 698) with videos related to

Pageof 70
Sort By:
Blood Advances|January 11, 2024
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Nitin Jain, et al.
JCO Oncology Practice|July 16, 2024
Outcomes of Patients With Newly Diagnosed AML and HyperleukocytosisFadi G Haddad, Koji Sasaki, Jayastu Senapati, et al.
Proceedings of the American Thoracic Society|January 10, 2009
Strategic plan for pediatric respiratory diseases research: an NHLBI working group reportMario Castro, Maria I Ramirez, James E Gern, et al.
American Journal of Human Genetics|August 20, 2013
Whole-genome sequencing uncovers the genetic basis of chronic mountain sickness in Andean highlandersDan Zhou, Nitin Udpa, Roy Ronen, et al.
Genome Biology|February 22, 2014
Whole genome sequencing of Ethiopian highlanders reveals conserved hypoxia tolerance genesNitin Udpa, Roy Ronen, Dan Zhou, et al.
Blood Advances|March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensityAlexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
The Lancet. Haematology|November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trialElias Jabbour, Nicholas J Short, Nitin Jain, et al.
Haematologica|December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasmsJayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
Leukemia|July 14, 2023
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapiesBranko Cuglievan, Jeremy Connors, Jiasen He, et al.
Molecular Psychiatry|November 12, 2014
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neuronsK Griesi-Oliveira, A Acab, A R Gupta, et al.
Pageof 70

Showing results (681-690 of 698) with videos related to

Sort By:
Pageof 70
Blood Advances|January 11, 2024
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Nitin Jain, et al.
JCO Oncology Practice|July 16, 2024
Outcomes of Patients With Newly Diagnosed AML and HyperleukocytosisFadi G Haddad, Koji Sasaki, Jayastu Senapati, et al.
Proceedings of the American Thoracic Society|January 10, 2009
Strategic plan for pediatric respiratory diseases research: an NHLBI working group reportMario Castro, Maria I Ramirez, James E Gern, et al.
American Journal of Human Genetics|August 20, 2013
Whole-genome sequencing uncovers the genetic basis of chronic mountain sickness in Andean highlandersDan Zhou, Nitin Udpa, Roy Ronen, et al.
Genome Biology|February 22, 2014
Whole genome sequencing of Ethiopian highlanders reveals conserved hypoxia tolerance genesNitin Udpa, Roy Ronen, Dan Zhou, et al.
Blood Advances|March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensityAlexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
The Lancet. Haematology|November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trialElias Jabbour, Nicholas J Short, Nitin Jain, et al.
Haematologica|December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasmsJayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
Leukemia|July 14, 2023
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapiesBranko Cuglievan, Jeremy Connors, Jiasen He, et al.
Molecular Psychiatry|November 12, 2014
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neuronsK Griesi-Oliveira, A Acab, A R Gupta, et al.
Pageof 70